合計 50 件の最近のインサイダー取引記録が記録されています Vera Therapeutics, Inc. (VERA), 内訳は 28 件の買い および 18 件の売り. インサイダー買い総額は $27.59M インサイダー売り総額は $4.28M.
最近活動のある主要インサイダーには Wright-mitchell Jane, Young Joseph R, Hite Christopher. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — VERA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-23 |
Wright-mitchell Jane |
Officer |
不明 |
- |
- |
- |
- |
| 2026-03-23 |
Wright-mitchell Jane |
Chief Legal Officer |
RSU 付与（制限付株式） |
42,403 |
- |
- |
42,403 |
| 2026-03-13 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
オプション行使（売却） |
10,000 |
$3.94 |
$39.4K |
38,589 |
| 2026-03-05 |
Hite Christopher |
Officer |
不明 |
- |
- |
- |
- |
| 2026-03-05 |
Hite Christopher |
Director |
RSU 付与（制限付株式） |
24,937 |
$38.85 |
$968.8K |
24,937 |
| 2026-02-23 |
Johnson David Lee |
Chief Operating Officer |
情報に基づく売り |
2,579 |
$41.98 |
$108.28K |
45,727 |
| 2026-02-23 |
Turner William D. |
Chief Regulatory Officer |
情報に基づく売り |
2,187 |
$41.98 |
$91.82K |
45,313 |
| 2026-02-23 |
Fordyce Marshall |
President and CEO |
情報に基づく売り |
16,925 |
$41.98 |
$710.58K |
257,163 |
| 2026-02-23 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
情報に基づく売り |
3,117 |
$41.98 |
$130.86K |
64,722 |
| 2026-02-23 |
Grant Sean |
Chief Financial Officer |
情報に基づく売り |
4,949 |
$41.98 |
$207.78K |
114,181 |
| 2026-02-23 |
Brenner Robert |
Chief Medical Officer |
情報に基づく売り |
2,151 |
$41.98 |
$90.31K |
50,947 |
| 2026-02-23 |
Skelton Laurence Matthew |
Chief Commercial Officer |
情報に基づく売り |
1,582 |
$41.98 |
$66.42K |
64,218 |
| 2026-02-04 |
Johnson David Lee |
Chief Operating Officer |
RSU 付与（制限付株式） |
40,000 |
$42.74 |
$1.71M |
40,000 |
| 2026-02-04 |
Turner William D. |
Chief Regulatory Officer |
RSU 付与（制限付株式） |
25,000 |
- |
- |
47,500 |
| 2026-02-04 |
Fordyce Marshall |
President and CEO |
RSU 付与（制限付株式） |
137,500 |
$42.74 |
$5.88M |
137,500 |
| 2026-02-04 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
RSU 付与（制限付株式） |
20,000 |
$42.74 |
$854.8K |
20,000 |
| 2026-02-04 |
Grant Sean |
Chief Financial Officer |
RSU 付与（制限付株式） |
50,000 |
$42.74 |
$2.14M |
50,000 |
| 2026-02-04 |
Brenner Robert |
Chief Medical Officer |
RSU 付与（制限付株式） |
50,000 |
$42.74 |
$2.14M |
50,000 |
| 2026-02-04 |
Skelton Laurence Matthew |
Chief Commercial Officer |
RSU 付与（制限付株式） |
40,000 |
$42.74 |
$1.71M |
40,000 |
| 2026-01-20 |
Skelton Laurence Matthew |
Chief Commercial Officer |
不明 |
31,500 |
$29.18 |
$919.17K |
- |
| 2025-12-15 |
Turner William D. |
Chief Regulatory Officer |
情報に基づく売り |
10,000 |
$50.08 |
$500.77K |
22,500 |
| 2025-12-11 |
Enright Patrick G |
Director |
情報に基づく買い |
5,882 |
$42.50 |
$249.99K |
5,882 |
| 2025-12-08 |
Turner William D. |
Chief Regulatory Officer |
情報に基づく売り |
10,000 |
$45.31 |
$453.05K |
22,500 |
| 2025-12-03 |
Turner William D. |
Chief Regulatory Officer |
情報に基づく売り |
10,000 |
$40.00 |
$400K |
22,500 |
| 2025-11-25 |
Meyers James R |
Officer |
不明 |
- |
- |
- |
- |
| 2025-11-25 |
Meyers James R |
Director |
RSU 付与（制限付株式） |
25,000 |
$29.43 |
$735.75K |
25,000 |
| 2025-11-21 |
Carter Jason S |
Chief Legal Officer |
情報に基づく売り |
3,864 |
$27.82 |
$107.5K |
49,136 |
| 2025-11-13 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
オプション行使（売却） |
10,000 |
$3.94 |
$39.4K |
48,589 |
| 2025-11-11 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
情報に基づく売り |
15,000 |
$29.06 |
$435.87K |
47,839 |
| 2025-06-24 |
Enright Patrick G |
Director |
情報に基づく買い |
13,536 |
$22.35 |
$302.55K |
1,797,619 |
| 2025-06-23 |
Enright Patrick G |
Director |
情報に基づく買い |
69,798 |
$20.87 |
$1.46M |
1,784,083 |
| 2025-05-14 |
Seidenberg Beth C |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Morrissey Michael |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Enright Patrick G |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Morrison Scott W |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Katabi Maha |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Cheng Andrew |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Oliger Christy J. |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Hall Kimball |
Director |
RSU 付与（制限付株式） |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-02-26 |
Fordyce Marshall |
President and CEO |
情報に基づく売り |
1,100 |
$28.32 |
$31.15K |
204,665 |
| 2025-02-21 |
Fordyce Marshall |
President and CEO |
情報に基づく売り |
10,613 |
$27.89 |
$296.03K |
213,740 |
| 2025-02-18 |
Johnson David Lee |
Chief Operating Officer |
RSU 付与（制限付株式） |
26,900 |
- |
- |
26,900 |
| 2025-02-18 |
Turner William D. |
Chief Development Officer |
RSU 付与（制限付株式） |
22,500 |
- |
- |
22,500 |
| 2025-02-18 |
Fordyce Marshall |
President and CEO |
RSU 付与（制限付株式） |
161,500 |
$29.18 |
$4.71M |
161,500 |
| 2025-02-18 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
RSU 付与（制限付株式） |
21,500 |
$29.18 |
$627.37K |
21,500 |
| 2025-02-18 |
Grant Sean |
Chief Financial Officer |
RSU 付与（制限付株式） |
53,800 |
$29.18 |
$1.57M |
53,800 |
| 2025-02-18 |
Brenner Robert |
Chief Medical Officer |
RSU 付与（制限付株式） |
26,900 |
- |
- |
27,474 |
| 2025-01-08 |
Fordyce Marshall |
President and CEO |
情報に基づく売り |
9,975 |
$41.53 |
$414.3K |
143,603 |
| 2024-12-19 |
Fordyce Marshall |
President and CEO |
オプション行使 |
57,661 |
$2.90 |
$167.03K |
143,603 |
| 2024-12-18 |
Fordyce Marshall |
President and CEO |
情報に基づく売り |
3,772 |
$41.33 |
$155.88K |
85,942 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
